New study aims to sharpen diagnosis of celiac disease using AI and genetics

NCT ID NCT07556328

Recruiting now Knowledge-focused Sponsor: Tampere University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is collecting small intestine tissue samples from 300 adults to better understand and diagnose celiac disease and other small-bowel conditions. Researchers will use advanced techniques like AI image analysis and genetic profiling to create more reliable diagnostic tools. Participants include healthy individuals, those being tested for celiac disease, and patients with persistent gut damage despite a gluten-free diet.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to more accurate and faster diagnosis of celiac disease and better ways to monitor treatment response.
What could go wrong: This is an observational study, not testing a new treatment. The findings may not directly change patient care for years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

celiac disease refractory celiac disease small intestine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CELIAC DISEASE REFRACTORY CELIAC DISEASE SMALL BOWEL DISEASE

Contacts and locations

Locations

Hatanpää Specialist Medical Care
RECRUITING

Tampere, 33720, Finland
Tampere University Hospital (Tays)
RECRUITING

Tampere, 33720, Finland
Valkeakoski Regional Hospital
RECRUITING

Valkeakoski, 33720, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.